This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Grivel, J.-C. & Margolis, L. CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue. Nature Med. 5, 344–346 ( 1999).
Andersson, J. et al. Early reduction of immune activation in lymphoid tissue following highly active HIV therapy. AIDS 12, F123 –F129 (1998).
Bleul, C.C., Wu, L., Hoxie, J.A., Springer, T.A. & Mackay, C.R. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc. Natl. Acad. Sci. USA 94, 1925–1930 ( 1997).
Shearer, G.M. & Clerici, M. Cytokine profiles in HIV type 1 disease and protection. AIDS Res. Hum. Retroviruses 14 Suppl 2, S149–S152 ( 1998).
Glushakova, S. et al. Evidence for the HIV-1 phenotype switch as a causal factor in acquired immunodeficiency. Nature Med. 4, 346–349 (1998).
Margolis, L.B., Glushakova, S., Grivel, J.C. & Murphy, P.M. Blockade of CC chemokine receptor 5 (CCR5)-tropic human immunodeficiency virus-1 replication in human lymphoid tissue by CC chemokines. J. Clin. Invest. 101, 1876–1880 ( 1998).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Landay, A., Patterson, B. & Andersson, J. Cytokine modulation of HIV-1 chemokine receptor expression. Nat Med 5, 592 (1999). https://doi.org/10.1038/9418
Issue date:
DOI: https://doi.org/10.1038/9418